Physician profile
Christopher B Boatwright
NPI 1780928481
$307.83
in general payments reported to CMS, 2019-2025
9 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $51.25 · 2024: $20.58 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $97.06 | 2025 | |
| Smith+Nephew, INC. | $55.85 | 2023-2025 | Aetos Shoulder System |
| Bioventus LLC | $37.42 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $31.91 | 2025 | Euflexxa |
| Amgen INC. | $20.58 | 2024 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $18.45 | 2025 | Exparel, Zilretta, Iovera |
| Depuy Synthes Sales INC. | $16.84 | 2025 | Monovisc |
| Cumberland Pharmaceuticals, INC. | $16.70 | 2025 | Caldolor |
| Orthofix Medical, INC. | $13.02 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Boatwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.